ALT

ALT

USD

Altimmune Inc. Common Stock

$4.110+0.190 (4.847%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$3.920

高値

$4.160

安値

$3.775

出来高

2.59M

企業ファンダメンタルズ

時価総額

428.8M

業種

バイオテクノロジー

United States

取引統計

平均出来高

2.84M

取引所

NGM

通貨

USD

52週レンジ

安値 $2.9現在値 $4.110高値 $11.16

関連ニュース

GlobeNewswire

Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder

Enrollment completed ahead of schedule, underscoring strong interest from patient community in a potential new therapeutic option On track to complete the 24-week treatment period and announce topline results in 2026

もっと見る
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
Reuters

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war

Metsera has become the obesity drug market's hottest ticket.

もっと見る
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
GlobeNewswire

Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025

GAITHERSBURG, Md., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases,

もっと見る
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025